--- title: "Berberine: AMPK, Metabolic Health & Best Supplement | Magellan" description: "Berberine activates AMPK and supports blood sugar and metabolic health. The evidence, dosing, and the best berberine supplement, with PubMed citations." url: "https://magellanlongevity.com/berberine.md" canonical: "https://magellanlongevity.com/berberine.html" html: "https://magellanlongevity.com/berberine.html" type: "landing" section: "Berberine" products: 1 citations: 18 updated: 2026-09-02 author: "Gabriel Radu, DO" author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765." publisher: "Magellan Longevity" content_format: "markdown" --- # Berberine: AMPK and metabolic health [Home](https://magellanlongevity.com/) › Berberine **HTML version:** https://magellanlongevity.com/berberine.html · **In the Magellan app:** https://magellanlongevity.com/#/cat/1 *Berberine is a plant alkaloid that activates AMPK — the same energy-sensing pathway as fasting and metformin — and is studied for blood sugar and lipids. Here is the evidence.* ## What berberine does **Berberine** activates AMPK, the cellular energy sensor switched on by exercise and fasting. Meta-analyses of human trials show meaningful improvements in fasting glucose, HbA1c, and lipids. It is not a normal dietary nutrient, so a standardized supplement is the practical route — and exercise and time-restricted eating engage the same pathway. ## Berberine supplements, graded Linked to mechanism and PubMed citations. | Product | Evidence grade | Citations | Typical price | Why it is on this list | | --- | --- | --- | --- | --- | | [Berberine HCl 500 mg (AMPK)](https://magellanlongevity.com/p/9.md) | Moderate evidence | 18 | $18.95 | In randomized trials and their meta-analyses in type 2 diabetes, berberine has produced significant reductions in… | ## Evidence detail ### Berberine HCl 500 mg (AMPK) - **Evidence grade:** Moderate evidence - **Dose used in studies:** Human trials typically use berberine HCl 500 mg two to three times daily (about 1,000–1,500 mg/day) for 8–24 weeks, lowering blood glucose and lipids comparably to metformin in some studies. - **Dose from food:** Not meaningfully obtained from food: berberine comes from medicinal plants (barberry, goldenseal, Oregon grape root) used as extracts; edible barberry berries contain only traces, so matching a 500 mg dose from food is impractical. - **What the grade does not say:** Meta-analyses of dozens of RCTs show metformin-like reductions in fasting glucose and HbA1c (~0.6–0.9%), but the trial base is small, short and mostly Chinese, with no large rigorous confirmatory trials and no hard-outcome data. Weight-loss effects are weak despite 'nature's Ozempic' hype. GI upset is common and berberine inhibits CYP3A4/2D6, so drug interactions are a real concern — not a substitute for prescribed medication. ## Frequently asked questions ### What does berberine do? It activates AMPK and has human trial evidence for improving fasting glucose, HbA1c, and cholesterol. ### What is the berberine dose? Trials commonly use ~500 mg two to three times daily with meals. Check with your physician, especially if you take medication. ### Is berberine like metformin? Both activate AMPK and lower blood sugar; berberine is sometimes called 'nature's metformin,' though metformin has far more outcome data. ### Is berberine safe? It is generally well tolerated but can interact with medications and cause GI upset; talk to your physician before use. ## The research behind these picks Primary peer-reviewed sources for the products above. Quotes are verbatim from the cited abstract. ### Cited studies 1. **The effect of Berberine on weight loss in order to prevent obesity: A systematic review** Biomedicine & Pharmacotherapy 2020 · [PMID 32353823](https://pubmed.ncbi.nlm.nih.gov/32353823/) · [DOI 10.1016/j.biopha.2020.110137](https://doi.org/10.1016/j.biopha.2020.110137) > Berberine and its effect on management of obesity and the related metabolic consequences were evaluated across in vitro, animal and human studies. 2. **The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-analysis** Clin Ther 2023 · [PMID 38016844](https://pubmed.ncbi.nlm.nih.gov/38016844/) · [DOI 10.1016/j.clinthera.2023.10.019](https://doi.org/10.1016/j.clinthera.2023.10.019) > berberine was effective in reducing fasting blood glucose and hemoglobin A1C 3. **The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.** Oxid Med Cell Longev 2021 · [PMID 34956436](https://pubmed.ncbi.nlm.nih.gov/34956436/) · [DOI 10.1155/2021/2074610](https://doi.org/10.1155/2021/2074610) > Analysis of berberine applied alone or with standard diabetic therapies versus the control group revealed significant reductions in HbA1c (MD = -0.73; 95% CI (-0.97, -0.51)), FPG (MD = -0.86, 95% CI (-1.10, -0.62)), and 2hPG (MD = -1.26, 95% CI (-1.64, -0.89)). 4. **Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study.** PLoS One 2026 · [PMID 42213651](https://pubmed.ncbi.nlm.nih.gov/42213651/) · [DOI 10.1371/journal.pone.0348907](https://doi.org/10.1371/journal.pone.0348907) > Probiotics, synbiotics, and BBR provide statistically significant but clinically modest improvements in glycemic control. These findings support their use as adjunctive, rather than primary, therapeutic options and highlight the need for larger and longer trials with standardized interventions. 5. **Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.** Evid Based Complement Alternat Med 2012 · [PMID 23118793](https://pubmed.ncbi.nlm.nih.gov/23118793/) · [DOI 10.1155/2012/591654](https://doi.org/10.1155/2012/591654) > Berberine appeared to be efficacious for treating hyperglycaemia and dyslipidemia in T2DM. However, the evidence of berberine for treating T2DM should be carefully interpreted due to the low methodological quality, small sample size, limited number of trials, and unidentified risks of bias. 6. **Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.** J Ethnopharmacol 2014 · [PMID 25498346](https://pubmed.ncbi.nlm.nih.gov/25498346/) · [DOI 10.1016/j.jep.2014.09.049](https://doi.org/10.1016/j.jep.2014.09.049) > This study indicates that berberine has comparable therapeutic effect on type 2 DM, hyperlipidemia and hypertension with no serious side effect. 7. **Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.** Drugs 2023 · [PMID 36941490](https://pubmed.ncbi.nlm.nih.gov/36941490/) · [DOI 10.1007/s40265-023-01841-4](https://doi.org/10.1007/s40265-023-01841-4) > Berberine produces small reductions in LDL cholesterol, triglycerides, and apolipoprotein B, with potential sex-specific effects on HDL cholesterol. Large-scale trials that consider sex disparity and assess clinical outcomes are required. 8. **Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials.** Phytomedicine 2018 · [PMID 30466986](https://pubmed.ncbi.nlm.nih.gov/30466986/) · [DOI 10.1016/j.phymed.2018.09.212](https://doi.org/10.1016/j.phymed.2018.09.212) > Berberine improves lipid profiles in dyslipidaemias with satisfactory safety. Nevertheless, these findings should be interpreted with caution because of the high clinical heterogeneity and high risk of bias in the included trials. 9. **The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials.** Planta Med 2013 · [PMID 23512497](https://pubmed.ncbi.nlm.nih.gov/23512497/) · [DOI 10.1055/s-0032-1328321](https://doi.org/10.1055/s-0032-1328321) > In conclusion, berberine may have beneficial effects in the control of blood lipid levels. However, the efficacy of berberine in treating hyperlipidemia should be further evaluated by more randomized controlled trials in a larger population of patients. 10. **Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.** Am J Chin Med 2019 · [PMID 31094214](https://pubmed.ncbi.nlm.nih.gov/31094214/) · [DOI 10.1142/S0192415X19500393](https://doi.org/10.1142/S0192415X19500393) > This study suggests that berberine is effective for hyperlipidemia. The quality and quantity of included studies, however, were dissatisfactory, which might decrease the reliability of the results. 11. **Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials.** Phytomedicine 2023 · [PMID 36805484](https://pubmed.ncbi.nlm.nih.gov/36805484/) · [DOI 10.1016/j.phymed.2023.154716](https://doi.org/10.1016/j.phymed.2023.154716) > This study suggests that berberine may be a promising alternative for CVDs with no serious adverse reactions. However, our results may be limited by the quality of existing research. 12. **Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.** Phytother Res 2019 · [PMID 30632209](https://pubmed.ncbi.nlm.nih.gov/30632209/) · [DOI 10.1002/ptr.6282](https://doi.org/10.1002/ptr.6282) > The present findings suggest that the coadministration of berberine and silymarin is associated with an advantageous improvement in lipid and glucose profile, suggesting the possible use of this nutraceutical combination in order to promote the cardiometabolic health. ## Structured data ```json {"@context":"https://schema.org","@graph":[{"@type":"MedicalWebPage","@id":"https://magellanlongevity.com/berberine.html#page","url":"https://magellanlongevity.com/berberine.html","name":"Berberine: AMPK and metabolic health","description":"Berberine activates AMPK and supports blood sugar and metabolic health. The evidence, dosing, and the best berberine supplement, with PubMed citations.","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/berberine.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Berberine","item":"https://magellanlongevity.com/berberine.html"}]},{"@type":"FAQPage","@id":"https://magellanlongevity.com/berberine.html#faq","mainEntity":[{"@type":"Question","name":"What does berberine do?","acceptedAnswer":{"@type":"Answer","text":"It activates AMPK and has human trial evidence for improving fasting glucose, HbA1c, and cholesterol."}},{"@type":"Question","name":"What is the berberine dose?","acceptedAnswer":{"@type":"Answer","text":"Trials commonly use ~500 mg two to three times daily with meals. Check with your physician, especially if you take medication."}},{"@type":"Question","name":"Is berberine like metformin?","acceptedAnswer":{"@type":"Answer","text":"Both activate AMPK and lower blood sugar; berberine is sometimes called 'nature's metformin,' though metformin has far more outcome data."}},{"@type":"Question","name":"Is berberine safe?","acceptedAnswer":{"@type":"Answer","text":"It is generally well tolerated but can interact with medications and cause GI upset; talk to your physician before use."}}]},{"@type":"ItemList","@id":"https://magellanlongevity.com/berberine.html#items","numberOfItems":1,"itemListElement":[{"@type":"ListItem","position":1,"name":"Berberine HCl 500 mg (AMPK)","url":"https://magellanlongevity.com/p/9.html"}]}]} ``` ## Related on Magellan Longevity - [Berberine HCl 500 mg (AMPK)](https://magellanlongevity.com/p/9.md) - [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md) - [Senolytics](https://magellanlongevity.com/senolytics.md) - [Best NMN supplements](https://magellanlongevity.com/best-nmn.md) - [Urolithin A](https://magellanlongevity.com/urolithin-a.md) - [Longevity research map](https://magellanlongevity.com/longevity-research-map.html) ## Scope and disclosures Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication. Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases. Reviewed for accuracy by a board-certified physician (DO).